Skip to main content

Bioadaptives, Inc.

BDPT
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001575142

No open-market purchases or sales by Bioadaptives, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of BDPT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Bioadaptives, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Bioadaptives, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Bioadaptives, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on BDPT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 22, 2024Keener James13DOld format–New–SEC
Oct 22, 2024Azuna Health LLC13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Bioadaptives, Inc. shares.

No Form 144 notices for Bioadaptives, Inc. are on file.